Araccel has received a $600,000 contract from one of the largest pharmaceutical companies in the world for use of its Araccel Solutions Platform (ASPlatform) and ASPocketTrial in a global, multiple-site, multi-language clinical trial. The trial will be deployed in over 100 sites worldwide.
Araccel has integrated ASPocketTrial into the Araccel Solutions Platform (ASPlatform). A key component of Araccel’s software and services in these electronic trials is the ability to integrate handheld computer devices, phone server and ASPlatform capabilities in order to convert paper documentation into electronic databases for these projects.
I am very pleased with the increased market reception of ASPlatform and the recently introduced ASPocketTrial. The strength of our solution lies in its fully integrated modular component and platform capabilities. The recent success in selling our new technology solutions is based on our global experience and proven success getting new drugs approved. Araccel has supported ten approved drugs that are now on the market, said Dr Jim Conklin, CEO of Araccel, in a news release.